Conjunctivitis Market Will Generate Booming Growth Opportunities to 2032

The global conjunctivitis market is anticipated to portray a phenomenal growth opportunity by exhibiting a 5.8% CAGR with a valuation of US$ 1825.8 Million by 2022. The market is expected to surpass about US$ 3208.7 Million by 2032.

The increasing prevalence of diseases and novel treatment options is surging the demand for the conjunctivitis market globally. There is a variety of conjunctivitis such as swelling of the conjunctiva, a tissue covering the white porting of the eye, which is called allergic conjunctivitis caused by an allergy.

It is usually caused due to allergens found in patients which can be traced from household dust, pollen from grass and trees, animal dander, and chemical scents. There are several treatment options, some of which include oral medications, immunotherapy, and eye drops among others.

Competitive Landscape

The prominent players in the market are planning to invest in research and development initiatives to innovate new drugs and therapies for efficiently treating ocular disorders. The recent awareness of ocular allergies has tremendously elevated backed by numerous factors such as faster urbanization and a growing number of allergens.

Key Companies Profiled

  • Boehringer Ingelheim GmbH
  • Allergan Inc.
  • Sanofi-Aventis
  • Atopix Therapeutics Ltd.
  • Novartis AG, Ocular Therapeutix, Inc.
  • Bausch & Lomb Inc.
  • Akorn Incorporated.
  • Auven Therapeutics
  • Sirion Therapeutics, Inc.
  • Sun Pharma Advanced Research Company Ltd.,
  • Boehringer Ingelheim International GmbH.
  • IBA Vision Ophthalmics
  • Pfizer Inc.
  • Merck & Co., Inc.
  • Santen Pharmaceuticals Co. Ltd.

Browse More@ https://www.futuremarketinsights.com/reports/allergic-conjunctivitis-treatment-market

Key Segments of the Conjunctivitis Market

By Type:

  • Giant Papillary Conjunctivitis
  • Seasonal Allergic Conjunctivitis
  • Vernal Keratoconjunctivitis
  • Contact Conjunctivitis
  • Perennial Conjunctivitis
  • Atopic Keratoconjunctivitis

By Treatment:

  • Mast Cell Stabilizers
  • Decongestant
  • Immunotherapy
  • Antihistamines
  • Non-steroidal Anti-Inflammatory Drugs
  • Olopatadine
  • Epinastine
  • Ointments
  • Others

Comments

Popular posts from this blog

Handheld Ultrasound Scanners Market Will Generate Booming Growth Opportunities to 2032

Global Medical face shield Market Insights and Outlook 2022-2032

Aesthetic Medical Devices Market 2022-2032: Advanced R&D Process Strategies